Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

Published:2012-03-02 Issue:1 Volume:7 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Habermehl Daniel,Kessel Kerstin,Welzel Thomas,Hof Holger,Abdollahi Amir,Bergmann Frank,Rieken Stefan,Weitz Jürgen,Werner Jens,Schirmacher Peter,Büchler Markus W,Debus Jürgen,Combs Stephanie E

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-7-28.pdf

Reference38 articles.

1. Bramhall SR, Allum WH, Jones AG, et al.: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995, 82: 111-115. 10.1002/bjs.1800820137

2. Sener SF, Fremgen A, Menck HR, et al.: Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999, 189: 1-7. 10.1016/S1072-7515(99)00075-7

3. Dunst J, Debus J, Rudat V, et al.: Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Strahlenther Onkol 2008, 184: 450-456. 10.1007/s00066-008-1751-4

4. Eich HT, Stepien A, Zimmermann C, et al.: Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer: prognostic significance of tumor regression. Strahlenther Onkol 2011, 187: 225-230. 10.1007/s00066-011-2113-1

5. Leibl BJ, Vitz S, Schafer W: Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery: early results and toxicity. Strahlenther Onkol 2011, 187: 231-237. 10.1007/s00066-011-2171-4

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma;Current Problems in Surgery;2024-03

2. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma;American Journal of Clinical Oncology;2023-12-22

3. Pancreatic adenocarcinoma — current trends in diagnosis and treatment;Oncology in Clinical Practice;2023-08-23

4. Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer;Cancers;2022-12-13

5. Lipid Nanoparticle Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Radiosensitizers in the Treatment of Pancreatic Cancer.;2022-10-14